XTX Topco’s Sonoma Pharmaceuticals SNOA Stock Holding History

XTX Topco’s Portfolio SNOA Stock Details SNOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-992	Closed	-$4.21K	–	2572
2024 Q2	$4.21K	Buy	992 +169	+21%	+$601	﹤0.01%	1752
2024 Q1	$2.74K	Buy	+823	New	+$2.66K	﹤0.01%	1752

Other funds holding SNOA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

XTX Topco's SNOA Position: Q3 2024 in Review

XTX Topco sold out of Sonoma Pharmaceuticals (SNOA) in Q3 2024, closing a stake of 992 shares — an estimated $4.21K sold.

XTX Topco first reported a position in SNOA in Q1 2024 and held it in 2 quarters. The position peaked at $4.21K in Q2 2024. 14 funds tracked by Wall St. Rank hold SNOA as of Q3 2024.

XTX Topco reported no remaining Sonoma Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
XTX Topco sold 992 Sonoma Pharmaceuticals shares in Q3 2024, an estimated $4.21K.
XTX Topco first reported a position in Sonoma Pharmaceuticals in Q1 2024 and held it in 2 quarters.
XTX Topco's Sonoma Pharmaceuticals position peaked at $4.21K in Q2 2024.
14 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q3 2024.

Based on XTX Topco's 13F filing for Q3 2024, filed 14 Nov 2024.